APP下载

抗Jo—1抗体综合征临床分析

2017-04-05林舒缓郑祥雄

中国医学创新 2017年6期

林舒缓 郑祥雄

【摘要】 目的:分析17例抗Jo-1抗体综合征病例的临床特点。方法:选取本院2008年1月1日-2015年12月31日收治的Jo-1抗体综合征17例患者的臨床资料进行回顾分析。对17例患者的一般资料、临床表现、实验检查及治疗方法进行研究,并对其进行统计学分析。结果:17位患者中包括女11例,男6例,女性与男性的比例为1.8∶1,年龄33~69岁,平均(52.21±18.42)岁,病程1个月~8年,平均(25.27±9.93)个月。初治13例,复发病例4例。临床表现包括:肌炎、多关节炎、间质性肺炎、发热、技工手、雷诺现象。间质性肺炎发生率为100%。结论:抗Jo-1抗体综合征患者临床多以多关节炎或肌炎起病,肌炎程度一般较轻。ILD在抗Jo-1抗体综合征中发生率高,为患者主要死因,该病恶性肿瘤伴发率低。

【关键词】 抗Jo-1抗体综合征; 临床分析; 肌炎; 皮肌炎; 间质性肺炎

Clinical Analysis of Anti-Jo-1 Antibody Syndrome/LIN Shu-huan,ZHENG Xiang-xiong.//Medical Innovation of China,2017,14(06):044-047

【Abstract】 Objective:To analyze the clinical characteristics in 17 cases with anti-Jo-1 antibody syndrome.Method:The clinical data about 17 patients with anti-Jo-1 antibody syndrome in our hospital from January 1,2008 to December 31,2015 were reviewed.The clinical data,clinical manifestation,clinical examinations and treatment methods were investigated.Result:For 17 cases,there were 11 female cases and 6 male cases,the male/female ratio was 1.8∶1,the onset age ranged from 3 to 69 years old,the average age was(52.21±18.42)years old;the disease course was 1 month to 8 years;the average disease course was(25.27±9.93)month.There were 13 cured cases and 4 recurrent cases.The clinical characteristics included myositis,polyarthritis,interstitial pneumonia,fever,technical hand and Raynauds phenomenon.The incidence rate of interstitial pneumonia was 100%.Conclusion:Anti-Jo-1 antibody syndrome patients with arthritis or myositis onset myositis degree generally lighter.ILD anti-Jo-1 antibody syndrome in high incidence is the main cause of death in patients with low incidence of the disease associated with malignant tumor.

【Key words】 Anti-Jo-1 antibody syndrome; Clinical analysis; Myositis; Dermatomyositis; Interstitial pneumonia

First-authors address:Fujian Medical University Union Hospital,Fuzhou 350001,China

doi:10.3969/j.issn.1674-4985.2017.06.012

随着近年来相关研究的不断深入,很多学者指出,若有患者体内的抗Jo-1抗体检查结果为阳性,则其会出现一组特别的症候群,在临床被称为Jo-1抗体综合征[1-2]。对于Jo-1抗体综合征患者,其临床治疗效果较差,且停止治疗后病情容易反复发作,预后十分不理想。抗Jo-1抗体(抗组氨酰tRNA合成酶抗体)可在15%~25%多发性肌炎/皮肌炎患者中检测出阳性,是最常见的一种抗合成酶抗体[3-4]。但由于抗Jo-1抗体综合征是一种少见病,该病的流行病学研究很少。为使人们能够正确认识抗Jo-1抗体综合征,为了提高本院对该病治疗方法的合理性,本文对17例抗Jo-1抗体综合征患者的临床资料进行了回顾性分析,现将结果报道如下。

1 资料与方法

1.1 一般资料 选择2008年1月1日-2015年12月31日本院风湿科确诊为抗Jo-1抗体综合征或肌炎/皮肌炎或抗合成酶抗体综合征的患者17例。……

登录APP查看全文